Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · February 04, 2022

A Minimal Monitoring Approach for the Treatment of HCV

The Lancet Gastroenterology & Hepatology


Additional Info

The Lancet Gastroenterology & Hepatology
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial
Lancet Gastroenterol Hepatol 2022 Jan 10;[EPub Ahead of Print], SS Solomon, S Wagner-Cardoso, L Smeaton, LA Sowah, C Wimbish, G Robbins, I Brates, C Scello, A Son, A Avihingsanon, B Linas, D Anthony, EP Nunes, DA Kliemann, K Supparatpinyo, C Kityo, P Tebas, JA Bennet, J Santana-Bagur, CA Benson, M Van Schalkwyk, N Cheinquer, S Naggie, D Wyles, M Sulkowski

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading